MDMA-assisted psychotherapy for PTSD: Growing evidence for memory effects mediating treatment efficacy
This review (2023) explores the potential mechanisms behind the efficacy of MDMA-assisted psychotherapy for posttraumatic stress disorder (PTSD). The article examines recent preclinical and clinical evidence, focusing on MDMA's mnemonic (memory) effects, its impact on fear extinction and reconsolidation, and its relevance for PTSD treatment.
Authors
- Patrick Vizeli
- Kim Kuypers
Published
Abstract
The application of MDMA in conjunction with psychotherapy has in recent years seen a resurgence of clinical, scientific, and public interest in the treatment of posttraumatic stress disorder (PTSD). Clinical trials have shown promising safety and efficacy, but the mechanisms underlying this treatment form remain largely unestablished. This article explores recent preclinical and clinical evidence suggesting that the treatment’s efficacy may be influenced by the mnemonic effects of MDMA. We review data on the effects of MDMA on fear extinction and fear reconsolidation and the utility of these processes for PTSD treatment. We corroborate our findings by incorporating research from cognitive psychology and psychopharmacology and offer recommendations for future research.
Research Summary of 'MDMA-assisted psychotherapy for PTSD: Growing evidence for memory effects mediating treatment efficacy'
Introduction
Sarmanlu and colleagues situate their review within a renewed clinical and scientific interest in administering MDMA alongside psychotherapy for posttraumatic stress disorder (PTSD). They frame PTSD as a disorder in which the memory of traumatic events—particularly their accessibility, vividness, emotional intensity and centrality to identity—plays a central mediating role in symptoms such as intrusions, avoidance and hyperarousal. The paper contrasts a "Basic Mechanisms View" (traumatic memories governed by general memory mechanisms) with a "Special Mechanisms View" (trauma-specific memory disruption) and argues that accumulated evidence supports the primacy of basic autobiographical memory processes in PTSD pathology. The review sets out to examine whether mnemonic effects of MDMA—specifically influences on fear extinction and fear reconsolidation—could plausibly mediate the clinical benefits observed in MDMA-assisted psychotherapy for PTSD. To do so, the authors synthesise data from preclinical and clinical studies of MDMA's effects on learning, consolidation, extinction and reconsolidation of fear- and autobiographical-type memories, and integrate findings from cognitive psychology and psychopharmacology to recommend directions for future research. The extracted text does not specify a formal search strategy, inclusion criteria, or whether this is a systematic review or a narrative synthesis.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typemeta
- Journal
- Compound
- Topic
- Authors
- APA Citation
Sarmanlu, M., Kuypers, K. P., Vizeli, P., & Kvamme, T. L. (2024). MDMA-assisted psychotherapy for PTSD: Growing evidence for memory effects mediating treatment efficacy. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 128, 110843. https://doi.org/10.1016/j.pnpbp.2023.110843
References (38)
Papers cited by this study that are also in Blossom
Baggot, M. J., Kirkpatrick, M. G., Bedi, G. et al. · Journal of Psychopharmacology (2015)
Bahji, A., Forsyth, A., Groll, D. et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020)
Barone, W., Beck, J., Mitsunaga-Whitten, M. et al. · Journal of Psychoactive Drugs (2019)
Bedi, G., Cecchi, G. A., Slezak, D. F. et al. · Neuropsychopharmacology (2014)
Bedi, G., Hyman, D., De Wit, H. · Biological Psychiatry (2010)
Carhart-Harris, R. L., Wall, M. B., Erritzoe, D. et al. · International Journal of Neuropsychopharmacology (2013)
de la Torre, R., Farré, M., Roset, P. N. et al. · Annals of the New York Academy of Sciences (2006)
Dolder, P. C., Müller, F., Schmid, Y. et al. · Psychopharmacology (2017)
Doss, M. K., Weafer, J. J., Gallo, D. A. et al. · Neuropsychopharmacology (2017)
Feduccia, A. A., Jerome, L., Yazar-Klosinski, B. et al. · Frontiers in Psychiatry (2019)
Show all 38 referencesShow fewer
Feduccia, A. A., Mithoefer, M. C. · Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018)
Frye, C. G., Wardle, M. C., Norman, G. J. et al. · Pharmacology Biochemistry and Behavior (2014)
Gabay, A. S., Carhart-Harris, R. L., Mazibuko, N. et al. · Scientific Reports (2018)
Gorman, I., Belser, A. B., Jerome, L. et al. · Journal of Traumatic Stress (2020)
Greer, G. R. · Journal of Psychoactive Drugs (1986)
Hasler, F., Ludewig, S. · Journal of Psychopharmacology (2008)
Holze, F., Vizeli, P., Müller, F. et al. · Neuropsychopharmacology (2019)
Hysek, C. M., Fink, A., Simmler, L. D. et al. · Journal of Clinical Psychopharmacology (2013)
´dric, C., Hysek, M., Schmid, Y. et al. · Social Cognitive and Affective Neuroscience (2013)
Hysek, C. M., Vollenweider, F. X., Liechti, M. E. · BMJ Open (2010)
Jerome, L., Feduccia, A. A., Wang, J. B. et al. · Psychopharmacology (2020)
Kuypers, K. P. C., Ramaekers, J. G. · Journal of Psychopharmacology (2005)
Kuypers, K. P. C., Ramaekers, J. G. · Psychopharmacology (2006)
Lewis, C. R., Tafur, J., Spencer, S. et al. · Frontiers in Psychiatry (2023)
Liechti, M. E., Baumann, C., Gamma, A. et al. · Neuropsychopharmacology (2000)
Ly, C., Greb, A. C., Cameron, L. P. et al. · Cell Reports (2018)
Maples-Keller, J. L., Norrholm, S. D., Burton, M. et al. · Journal of Psychopharmacology (2022)
Mithoefer, M. C., Feduccia, A. A., Jerome, L. et al. · Psychopharmacology (2019)
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T. et al. · Journal of Psychopharmacology (2012)
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T. et al. · Journal of Psychopharmacology (2010)
Ot'alora G, M., Grigsby, J., Poulter, B. et al. · Journal of Psychopharmacology (2018)
Pantoni, M. M., Kim, J. L., Van Alstyne, K. R. et al. · Psychopharmacology (2022)
Singleton, S. P., Wang, J. B., Mithoefer, A. T. et al. · Frontiers in Psychiatry (2023)
Van Wel, J. H. P., Kuypers, K. P. C., Theunissen, E. L. et al. · PLOS ONE (2012)
Vizeli, P., Straumann, I., Duthaler, U. et al. · Frontiers in Pharmacology (2022)
Wardle, M. C., De Wit, H. · Psychopharmacology (2014)
Young, M. B., Andero, R., Ressler, K. J. et al. · Translational Psychiatry (2015)
Young, M. B., Norrholm, S. D., Khoury, L. M. et al. · Psychopharmacology (2017)
Cited By (2)
Papers in Blossom that reference this study
Ramaekers, J. G., Kuypers, K. P. C., Vollenweider, F. X. · Molecular Psychiatry (2026)
Kangaslampi, S., Zijlmans, J. · European Child and Adolescent Psychiatry (2023)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.